Our story

Sant Joan de Déu Research Foundation was created in 2002 to provide a framework for the research activity which is carried out in the biomedical and social spheres at Sant Joan de Déu Maternal and Children's
Hospital in Esplugues, at Sant Joan de Déu Healthcare Park in Sant Boi de Llobregat and in others.
Accordingly, we work jointly with centres of “Hospitaller Order of St. John of God – Aragon-San Rafael Province” to expand scientific knowledge and to improve the care given to people who suffer health problems. Moreover, we seek to achieve these ends in an integrated way within the healthcare sphere, always bearing closely in mind the persons who are ill and the members of their families. We approach our research as a participative and interdisciplinary process in which the interaction between our healthcare professionals and society.
The Foundation's fundamental aim is to contribute to the improvement of people's health and welfare by fostering, supporting and coordinating research and innovation. We strive to achieve efficiency and to strengthen our networked activities while always bearing closely in mind our institutional values and ethical commitment.
The research is organised around our Institut de Recerca Sant Joan de Déu and covers 7 areas of knowledge, primarily within the fields of maternal and children's health and mental health. We also have research groups working in other spheres.

Asserta Global Healthcare Solutions SL brings together a team of professionals with years of experience in clinical practice, health management, teaching and research, who are putting their knowledge and expertise at the service of improving processes and results in the healthcare area. While becoming a reference in the Medication management processes, and improving healthcare processes, we have opened a new lines of business related to innovation management, and social impact measurement in international projects. We have consolidated our expertise in Organization and Strategy, Social Innovation in International environments, Real World Data analysis, and international research consultancy. Our team also include experts in planning and strategic management, quality management, technology transfer, financing, information and communication technologies.

Cliclab is a non-conventional consulting agency from Barcelona that focuses on attitude as a driving force to transform corporations & societies. Cliclab unites a motivated, interdisciplinary and international team of experts with longstanding experience in developing and managing international research projects in fields such as Health and Migration, with special emphasis on innovation and social impact analysis. Additionally, Cliclab assesses and trains companies in soft & hard skills to faster innovation, leadership, entrepreneurship, business strategy and to support a positive working environment.

The John Walton Muscular Dystrophy Research Centre is part of the University of Newcastle upon Tyne and works to perform world-class translational research to bring diagnosis, care, and therapy to people with neuromuscular diseases. As a group, we have developed a close and important link between research and clinical activities and we actively pursue new partnerships with other stakeholders such as patient organisations, regulators and pharma. The John Walton Muscular Dystrophy Research Centre is structured around five important strands of activity – clinical care, clinical research, diagnostics, basic research and strategic partnerships and networking – but all are strongly interlinked and working across these teams is key to our success and impact in the neuromuscular field. To complement our neuromuscular expertise, the centre is also a key actor in European initiatives for rare diseases more broadly.

MPNE is a loose multidimensional network of European national and regional Melanoma patient forums advocating on behalf of patients and operating across language barriers with shared principles. Our mission is to systematically address problems faced by the European Melanoma community (Adult and Paediatric, Rare and less rare) in a constructive, result-oriented and collaborative manner by providing a platform for advocates to interact and through targeted capacity-building.

Òmada Interactiva is a company with 15 years of experience in consulting, support, design, creation, and development of interactive solutions, developed mostly on open source software. We are a multidisciplinary team focused on offering a solid, innovative and agile approach to web development, communities design, process management and online marketing.
Health, education, and NGOs are the three major axes we have specialized in.

The Synergist is a social venture that addresses a growing societal need for collaboration by building partnerships to accelerate societal impact.
The Synergist acts as an independent, neutral backbone and incubator bringing together the right people, organizations, and institutions together to focus on solving societal issues both personally and with technology tools.

The Universitat Politècnica de Catalunya-BarcelonaTech (Technical University of Catalonia, UPC, http://upc.edu) is a public institution dedicated to higher education and research, specialised in the fields of engineering, architecture and science. It offers higher education in technical fields (69 degrees) and it is composed by 23 schools in 8 different campuses, with a total of 35.000 students and 2.780 researchers. The UPC is ranked 1st in Spain in the Field of Engineering and Technology. UPC participates in Share4Rare from the Bioinformatics and Biomedical Signals Laboratory (B2SLab) at http://b2slab.upc.edu with data analysis technologies.

World Duchenne Organization/UPPMD is a worldwide organization owned and managed by parent project organizations set up by parents of children with Duchenne and Becker Muscular Dystrophy in many different countries all over the world. It is dedicated to finding a cure and viable treatments for DMD, to promoting good standards of care, and to informing parents around the globe.